|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | NSC 27223, Acetylsalicylic acid, ASA | Storage (From the date of receipt) |
3 years -20°C powder 1 years -80°C in solvent |
|||
| 化学式 | C9H8O4 |
||||||
| 分子量 | 180.16 | CAS No. | 50-78-2 | ||||
| Solubility (25°C)* | 体外 | DMSO | 36 mg/mL (199.82 mM) | ||||
| Ethanol | 36 mg/mL (199.82 mM) | ||||||
| Water | Insoluble | ||||||
| 体内 (毎回新しく調製した物を用意してください) |
|
||||||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||||||
| 製品説明 | Aspirin (NSC 27223、アセチルサリチル酸、ASA) はサリチル酸誘導体であり、不可逆的なCOX1 および COX2 阻害剤です。マイナーな痛みや痛みを和らげる鎮痛剤として、解熱剤として熱を下げるため、また抗炎症薬として使用されます。Aspirinはautophagyを誘発し、mitophagyを刺激します。 |
|---|---|
| in vitro | Aspirin inhibits the activation of NF-kappa B, thus prevents the degradation of the NF-kappa B inhibitor, I kappa B, and therefore NF-kappa B is retained in the cytosol. This compound also inhibits NF-kappa B-dependent transcription from the Ig kappa enhancer and the human immunodeficiency virus (HIV) long terminal repeat (LTR) in transfected T cells. It and salicylate are mediated in part by their specific inhibition of IKK-beta, thereby preventing activation by NF-kappaB of genes involved in the pathogenesis of the inflammatory response. This chemical is protective against neurotoxicity elicited by the excitatory amino acid glutamate in rat primary neuronal cultures and hippocampal slices. It triggers transcellular biosynthesis of a previously unrecognized class of eicosanoidsduring coincubations of human umbilical vein endothelial cells (HUVEC) and neutrophils [polymorphonuclear leukocytes (PMN)]. This agent evokes a unique class of eicosanoids formed by acetylated PGHS-2 and 5-lipoxygenase interactions. Its treatment inhibits the phosphorylation of IRS-1 at Ser307 as well as the phosphorylation of JNK, c-Jun, and degradation of IkappaBalpha in 3T3-L1 and Hep G2 cells treated with tumor necrosis factor (TNF)-alpha. This treatment inhibits phosphorylation of Akt and the mammalian target of rapamycin (but not extracellular regulated kinase or PKCzeta) in response to TNF-alpha. It rescues insulin-induced glucose uptake in 3T3-L1 adipocytes pretreated with TNF-alpha. |
|
| Protein kinase a suppresses antiproliferative effect of interferon-α in hepatocellular carcinoma by activation of protein tyrosine phosphatase SHP2 [ J Biol Chem, 2025, 301(2):108195] | PubMed: 39826687 |
| Lactic acid regulates antitumor immunity in canine invasive urothelial carcinoma [ PLoS One, 2025, 20(9):e0332825] | PubMed: 40966256 |
| Patient-derived rhabdomyosarcoma cells recapitulate the genetic and transcriptomic landscapes of primary tumors [ iScience, 2024, 27(10):110862] | PubMed: 39319271 |
| Synergistic antitumor efficacy of aspirin plus lenvatinib in hepatocellular carcinoma via regulating of diverse signaling pathways [ Cell Death Discov, 2023, 10.1038/s41420-023-01664-y] | PubMed: 37973900 |
| The potential therapeutic regimen for overcoming resistance to osimertinib due to rare mutations in NSCLC [ iScience, 2023, 26(7):107105] | PubMed: 37416479 |
| Scale bar of aging trajectories for screening personal rejuvenation treatments [ Comput Struct Biotechnol J, 2022, 20:5750-5760] | PubMed: 36382193 |
| Reversing PD-1 Resistance in B16F10 Cells and Recovering Tumour Immunity Using a COX2 Inhibitor [ Cancers (Basel), 2022, 14(17)4134] | PubMed: 36077671 |
| Establishment and Characterization of NCC-PMP1-C1: A Novel Patient-Derived Cell Line of Metastatic Pseudomyxoma Peritonei [ J Pers Med, 2022, 12(2)258] | PubMed: 35207746 |
| Establishment and characterization of NCC-UPS4-C1: a novel cell line of undifferentiated pleomorphic sarcoma from a patient with Li-Fraumeni syndrome [ Hum Cell, 2022, 10.1007/s13577-022-00671-y] | PubMed: 35118583 |
| Microenvironmental innate immune signaling and cell mechanical responses promote tumor growth [ Dev Cell, 2021, S1534-5807(21)00485-8] | PubMed: 34197724 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。